Genomic Data Set for Real World Evidence (RWE) Applications Market Size, Share, By Genomic Data Type (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and Targeted Sequencing), By Data (Structured Data, and Unstructured Data), By Patient Records (Electronic Health Records (EHRs), Claims Data, Patient Reported Outcomes (PROs)), By Application (Oncology, Cardiovascular, Neurology, Immunology, and Others), and Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis and Forecast till 2034

Demand for personalized medicine:

• The medical community is heading toward personalized medicine, which tailors patients' treatment to their unique genetic makeup. For this reason, genetic data sets linked to real-world experiences provide a multitude of information. By examining these databases, researchers can identify genetic polymorphisms influencing treatment response and disease risk.
• When a cancer patient undergoes genetic testing, for instance, when this data is linked to their medical history, it becomes evident how similar patients with the same genetic markers responded to different treatments. By doing this, doctors increase their ability to choose the optimal course of action for each patient, increasing the probability of a successful outcome.